ArticleEFSA journal. European Food Safety Authority2017
Annual post-market environmental monitoring (PMEM) report on the cultivation of genetically modified maize MON 810 in 2015 from Monsanto Europe S.A.
Article in EFSA journal. European Food Safety Authority, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Scientific assessment of the 2024 post-market environmental monitoring report on the cultivation of genetically modified maize MON 810 in the EU.EFSA journal. European Food Safety Authority · 2026Article
- Assessment of the 2023 post-market environmental monitoring report on the cultivation of genetically modified maize MON 810 in the EU.EFSA journal. European Food Safety Authority · 2025Article
- Assessment of the 2022 post-market environmental monitoring report on the cultivation of genetically modified maize MON 810 in the EU.EFSA journal. European Food Safety Authority · 2024Article
- Assessment of the 2021 post-market environmental monitoring report on the cultivation of genetically modified maize MON 810 in the EU.EFSA journal. European Food Safety Authority · 2023Article
- Monitoring Insect Resistance to Bt Maize in the European Union: Update, Challenges, and Future Prospects.Journal of economic entomology · 2023Article
- Assessment of the 2020 post-market environmental monitoring report on the cultivation of genetically modified maize MON 810 in the EU.EFSA journal. European Food Safety Authority · 2022Article
- Assessment of the 2019 post-market environmental monitoring report on the cultivation of genetically modified maize MON 810 in the EU.EFSA journal. European Food Safety Authority · 2021Article
- Assessment of the 2018 post-market environmental monitoring report on the cultivation of genetically modified maize MON 810 in the EU.EFSA journal. European Food Safety Authority · 2020Article
- Weight of the evidence: independent research projects confirm industry conclusions on the safety of insect-protected maize MON 810.GM crops & food · 2020Article
- Results from ten years of post-market environmental monitoring of genetically modified MON 810 maize in the European Union.PloS one · 2020Article
- Assessment of the 2017 post-market environmental monitoring report on the cultivation of genetically modified maize MON 810.EFSA journal. European Food Safety Authority · 2019Article
- Annual post-market environmental monitoring report on the cultivation of genetically modified maize MON 810 in 2016.EFSA journal. European Food Safety Authority · 2018Article
- Annual post-market environmental monitoring (PMEM) report on the cultivation of genetically modified maize MON 810 in 2015 from Monsanto Europe S.A.EFSA journal. European Food Safety Authority · 2017Article
- Article
- Scientific Opinion on the annual post-market environmental monitoring (PMEM) report from Monsanto Europe S.A. on the cultivation of genetically modified maize MON 810 in 2013.EFSA journal. European Food Safety Authority · 2015Article
- The use of massive sequencing to detect differences between immature embryos of MON810 and a comparable non-GM maize variety.PloS one · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Following a request from the European Commission, the Panel on Genetically Modified Organisms of the European Food Safety Authority (GMO Panel) assessed the annual post-market environmental monitoring (PMEM) report for the 2015 growing season of the Cry1Ab-expressing maize event MON 810 provided by Monsanto Europe S.A. The GMO Panel concludes that the insect resistance monitoring data submitted to EFSA do not indicate a decrease in susceptibility of field Iberian populations of corn borers to the Cry1Ab protein during the 2015 season. However, since the methodology for insect resistance monitoring remained unchanged compared to previous PMEM reports, the GMO Panel reiterates its previous recommendations on resistance monitoring to provide sufficient detection sensitivity. Although the farmer alert system to report complaints about product performance could complement the information obtained from the laboratory bioassays, the GMO Panel is currently not in a position to appraise its usefulness, and therefore encourages the consent holder to provide more information on this complementary resistance monitoring tool. The data on general surveillance (GS) do not indicate any unanticipated adverse effects on human and animal health or the environment arising from the cultivation of maize MON 810. The GMO Panel reiterates its previous recommendations on the analysis of farmer questionnaires, and advises the consent holder to provide more detailed information on the conducting and reporting of the literature search in future annual PMEM reports. Moreover, the GMO Panel encourages relevant parties to continue developing a methodological framework to use existing networks in the broader context of environmental monitoring. The GMO Panel concludes that the case-specific monitoring (CSM) and GS activities of maize MON 810 as carried out by the consent holder do not provide evidence that would invalidate previous GMO Panel evaluations on the safety of maize MON 810.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.